Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Mdart L, et al
We determine whether semaglutide is appropriate for obesity or weight management during the medical consultation and adjust the approach at regular follow-ups
Get In Touch With Us GLP-1 Lawsuit MDL Update (JuneNovember 2025) From June through November 2025, the GLP-1 receptor agonist multidistrict litigation (MDL 3094) expanded rapidly, with the number of pending lawsuits increasing from approximately 1,882 cases in early June to more than 2,900 cases by early November , according to reports from the Judicial Panel on Multidistrict Litigation (JPML)
Emily Mullin: Hi Mike
5b and c)
Banking is streamlined: deposits post instantly, verification steps are guided, and withdrawal clocks are displayed before you confirm